NPCE vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

NPCE

44.2
AI Score
VS
It's a Tie!

LUNG

44.2
AI Score

Investment Advisor Scores

NPCE

44score
Recommendation
HOLD

LUNG

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NPCE LUNG Winner
Forward P/E 166.6667 28.3286 LUNG
PEG Ratio 0 0 Tie
Revenue Growth 17.1% -4.6% NPCE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.2/100 44.2/100 Tie
Profit Margin -17.9% -55.0% NPCE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NPCE 1M: -3.6% · 3M: -11.4% LUNG 1M: -19.2% · 3M: +30.3%

Current Technical Phase

NPCE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 44

RSI (14): 43.8 · Price: $14.04

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.6 · Price: $1.85

Fundamentals Snapshot

Metric NPCE LUNG
Market Cap
Forward P/E -63.9 -2.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin -0.2% -0.4%
EPS -0.45 -1.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NPCE and LUNG are evenly matched. This is a close call that depends on your specific investment goals.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.